DPC 681 and DPC 684: Potent, Selective Inhibitors of Human Immunodeficiency Virus Protease Active against Clinically Relevant Mutant Variants

Схожие документы

• DPC 817: a Cytidine Nucleoside Analog with Activity against Zidovudine- and Lamivudine-Resistant Viral Variants
  по: Schinazi, Raymond F., et al.
  Опубликовано: (2002)
• Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1
  по: Corbett, Jeffrey W., et al.
  Опубликовано: (1999)
• Potency of Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) Used in Combination with Other Human Immunodeficiency Virus NNRTIs, NRTIs, or Protease Inhibitors
  по: King, Robert W., et al.
  Опубликовано: (2002)
• Potency and selectivity of inhibition of human immunodeficiency virus protease by a small nonpeptide cyclic urea, DMP 323.
  по: Erickson-Viitanen, S, et al.
  Опубликовано: (1994)
• Supplement 684
  Опубликовано: (1917)